Mid-America Chapter

www.lls.org/mid

Professional Education Programs


The Leukemia & Lymphoma Society (LLS) sponsors a number of free community-based professional education programs for healthcare professionals, particularly for oncology nurses and social workers. Patients, their families and caregivers are also invited to attend.

These programs are led by local doctors and other healthcare professionals and offer continuing education credits for nurses and social workers.

Click on the events listed below for more information. Local events will be updated periodically.

LLS national free CEU programs:

 

http://www.lls.org/#/researchershealthcareprofessionals/ce/ 

 

Lawrence Oncology Nurses Symposium

Lawrence Oncology Symposium

Lawrence Oncology Nurses Symposium

Regional Blood Cancer Symposia

Regional Blood Cancer Symposia

 

Tuesday, March 31, 2015

Acute Myeloid Leukemia (AML): Treatment Options, including BMT, Care and Support

Date: March 31, 2015
Time: 12:00 p.m. - 1:15 p.m. ET
Location: Telephone/Web
Target Audience: 
Hematology oncology and BMT nurses, hematology oncology and BMT social workers at all levels of experience and licensure, transplant center coordinators, and other allied health professionals.

Register

After you register, you will receive an email with information about how to participate by telephone or web.

Activity Purpose

In this free webinar, two physicians will address the risks and benefits of treatment options for patients with AML; how cytogenetics can help to inform clinicians' treatment decisions; and the impact of well-timed referral for blood and marrow transplantation (BMT) on outcomes for patients with high-risk AML. Two national organizations will highlight programs and resources to support patients and caregivers.

Education Objectives

After completing this activity, the participant should be better able to:

  • Describe the role of cytogenetics in determining AML subtypes
  • Compare the risks and benefits of treatment options for newly diagnosed, relapsed, and refractory AML
  • Explain the impact of timely BMT consultation
  • Identify educational programs and resources to support patients and caregivers

Faculty

Gail J. Roboz, MD   
Director, Clinical and Translational Leukemia Programs, Associate Professor of Medicine
, Weill Cornell Medical College of Cornell University and the New York-Presbyterian Hospital

Sergio A. Giralt, MD
Chief, Adult Bone Marrow Transplant Service, Memorial Sloan-Kettering Cancer Institute 
President
, American Society for Blood and Marrow Transplantation

Sponsors and Supporters

Sponsored jointly by The Leukemia & Lymphoma Society and the National Marrow Donor Program®/Be The Match®.

 

 

last updated on Tuesday, February 10, 2015
btn_sharethis